Literature DB >> 31200971

Embryonic cell-free DNA versus trophectoderm biopsy for aneuploidy testing: concordance rate and clinical implications.

Carmen Rubio1, Laura Rienzi2, Luis Navarro-Sánchez3, Danilo Cimadomo2, Carmen María García-Pascual3, Laura Albricci2, Daria Soscia2, Diana Valbuena4, Antonio Capalbo5, Filippo Ubaldi2, Carlos Simón6.   

Abstract

OBJECTIVE: To study whether embryonic cell-free DNA (cfDNA) in spent blastocyst media is representative of the chromosomal constitution of a blastocyst.
DESIGN: Pilot prospective blinded study.
SETTING: In vitro fertilization center and genetics laboratory. PATIENT(S): A total of 115 trophectoderm (TE) biopsies and spent blastocyst media (SBM) from 46 patients with ages ranging from 32 to 46 years, whose indications for preimplantation genetic testing of aneuploidy (PGT-A) were advanced maternal age, recurrent miscarriage, or recurrent implantation failure. INTERVENTIONS(S): Spent blastocyst media collection and TE biopsy. MAIN OUTCOME MEASURE(S): Concordance rates, sensitivity, and specificity between TE biopsies and SBM. Clinical outcomes in cases with euploid TE biopsies and euploid SBM compared with cases with euploid TE and aneuploid SBM. RESULT(S): In general, the total concordance rate for ploidy and sex was 78.7%, and sensitivity and specificity were 94.5% and 71.7%, respectively. A significant increase for all parameters was observed for day 6/7 samples compared with day 5 samples, with day 6/7 samples showing total concordance for ploidy and sex of 84%, and sensitivity and specificity of 95.2% and 82.1%, respectively. Ongoing implantation rates in euploid TE/euploid SBM showed a threefold increase compared with euploid TE/aneuploid SBM (52.9% vs. 16.7%, respectively), without reaching significant differences. Interestingly, no miscarriages were observed when TE and SBM were euploidy concordant. CONCLUSION(S): These results offer a better understanding of the dynamics of cfDNA during embryo development and despite more basic research being needed, they are reassuring to consider in the future this noninvasive approach as an alternative to TE biopsy for PGT-A.
Copyright © 2019 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Embryo; aneuploidy; noninvasive PGT-A; spent blastocyst media; trophectoderm biopsy

Mesh:

Substances:

Year:  2019        PMID: 31200971     DOI: 10.1016/j.fertnstert.2019.04.038

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  17 in total

Review 1.  Preimplantation Genetic Testing for Monogenic Conditions: Is Cell-Free DNA Testing the Next Step?

Authors:  Deirdre Zander-Fox; Tristan Hardy; Alice Rogers; Melody Menezes; Stefan C Kane
Journal:  Mol Diagn Ther       Date:  2021-09-08       Impact factor: 4.074

2.  Re-denudation of residual cumulus cells on day 3 increases the accuracy of cell-free DNA detection in spent embryo culture medium.

Authors:  Caixia Lei; Jing Fu; Xiong Li; Jing Zhou; Min Xiao; Shuo Zhang; Yijuan Sun; Xiaoxi Sun
Journal:  J Assist Reprod Genet       Date:  2022-06-07       Impact factor: 3.357

Review 3.  Cell-free DNA discoveries in human reproductive medicine: providing a new tool for biomarker and genetic assays in ART.

Authors:  Maryam Qasemi; Reza Mahdian; Fardin Amidi
Journal:  J Assist Reprod Genet       Date:  2021-01-09       Impact factor: 3.412

4.  End-to-end deep learning for recognition of ploidy status using time-lapse videos.

Authors:  Chun-I Lee; Yan-Ru Su; Chien-Hong Chen; T Arthur Chang; Esther En-Shu Kuo; Wei-Lin Zheng; Wen-Ting Hsieh; Chun-Chia Huang; Maw-Sheng Lee; Mark Liu
Journal:  J Assist Reprod Genet       Date:  2021-05-22       Impact factor: 3.357

5.  Minimally Invasive Cell-Free Human Embryo Aneuploidy Testing (miPGT-A) Utilizing Combined Spent Embryo Culture Medium and Blastocoel Fluid -Towards Development of a Clinical Assay.

Authors:  Valeriy Kuznyetsov; Svetlana Madjunkova; Rina Abramov; Ran Antes; Zenon Ibarrientos; Gelareh Motamedi; Afsaneh Zaman; Iryna Kuznyetsova; Clifford L Librach
Journal:  Sci Rep       Date:  2020-04-29       Impact factor: 4.379

6.  Noninvasive preimplantation genetic testing for aneuploidies (niPGT-A) and the principle of primum non nocere.

Authors:  Jose G Franco; Felipe Dieamant; Joao Batista A Oliveira
Journal:  JBRA Assist Reprod       Date:  2020-10-06

7.  Relationship between age and blastocyst chromosomal ploidy analyzed by noninvasive preimplantation genetic testing for aneuploidies (niPGT-A).

Authors:  Laura D Vagnini; Claudia G Petersen; Adriana Renzi; Felipe Dieamant; João B A Oliveira; Antonio H Oliani; Maria C T Canas; Raul Nakano; Carlos G Almodin; Condesmar Marcondes; Alvaro Ceschin; Adelino Amaral; Jonathas B Soares; Joaquim Lopes; Antonio C Franco; Jose G Franco
Journal:  JBRA Assist Reprod       Date:  2020-10-06

Review 8.  Preimplantation Genetic Testing for Chromosomal Abnormalities: Aneuploidy, Mosaicism, and Structural Rearrangements.

Authors:  Manuel Viotti
Journal:  Genes (Basel)       Date:  2020-05-29       Impact factor: 4.096

Review 9.  Current Advancements in Noninvasive Profiling of the Embryo Culture Media Secretome.

Authors:  Raminta Zmuidinaite; Fady I Sharara; Ray K Iles
Journal:  Int J Mol Sci       Date:  2021-03-03       Impact factor: 5.923

10.  Diagnostic efficiency of blastocyst culture medium in noninvasive preimplantation genetic testing.

Authors:  Jingbo Chen; Lei Jia; Tingting Li; Yingchun Guo; Shujing He; Zhiqiang Zhang; Wenlong Su; Shihui Zhang; Cong Fang
Journal:  F S Rep       Date:  2020-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.